FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022881140> ?p ?o ?g. }

• W2022881140 endingPage "1808" @default.
• W2022881140 startingPage "1801" @default.
• W2022881140 abstract "Concerns have been raised about patients' failure to persist in alcohol treatment. We examined prescriptions for oral naltrexone in a large, nationally distributed treatment population to identify characteristics and health-care utilization patterns associated with persistence.Data from the 2000-2004 MarketScan Commercial Claims and Encounters Database were used to identify patients with alcohol-related claims who were prescribed naltrexone.Analysis identified patient characteristics that predicted persistence with naltrexone (defined as having filled prescriptions for >or=80% of the 6-month treatment period) and its association to health-care utilization.Of 1138 patients, 162 (14.2%) were persistent in obtaining naltrexone. Non-persistent patients were significantly younger, more likely to be hourly employees and to live in an area with a lower median income, and less likely to be newly diagnosed with an alcohol-related disorder. Non-persistence in obtaining naltrexone was associated with significantly more intensive treatments, including inpatient detoxification, emergency room visits and hospitalizations.Over a 6-month period, 85.8% of patients who filled an initial prescription for naltrexone did not persist in obtaining the medication. Non-persistence was associated with significantly greater use of costly health-care services. Because the study was correlational, it is not possible to conclude that persistence reduced health-care costs, as patients with a better prognosis may have been more persistent. Research is needed to determine whether interventions that enhance persistence with naltrexone therapy improve treatment outcomes and reduce health-care costs." @default.
• W2022881140 created "2016-06-24" @default.
• W2022881140 creator A5009339235 @default.
• W2022881140 creator A5015054723 @default.
• W2022881140 creator A5021252267 @default.
• W2022881140 creator A5038414404 @default.
• W2022881140 creator A5075961872 @default.
• W2022881140 date "2008-11-01" @default.
• W2022881140 modified "2023-10-16" @default.
• W2022881140 title "Persistence with oral naltrexone for alcohol treatment: implications for health-care utilization" @default.
• W2022881140 cites W1633081414 @default.
• W2022881140 cites W1968751442 @default.
• W2022881140 cites W1975381773 @default.
• W2022881140 cites W1978554514 @default.
• W2022881140 cites W1993412733 @default.
• W2022881140 cites W2000125680 @default.
• W2022881140 cites W2022496892 @default.
• W2022881140 cites W2026933034 @default.
• W2022881140 cites W2030978638 @default.
• W2022881140 cites W2031611123 @default.
• W2022881140 cites W2048541373 @default.
• W2022881140 cites W2058924438 @default.
• W2022881140 cites W2067916767 @default.
• W2022881140 cites W2079726518 @default.
• W2022881140 cites W2086730289 @default.
• W2022881140 cites W2087081361 @default.
• W2022881140 cites W2087994176 @default.
• W2022881140 cites W2093686101 @default.
• W2022881140 cites W2104274635 @default.
• W2022881140 cites W2114168137 @default.
• W2022881140 cites W2118994821 @default.
• W2022881140 cites W2143913225 @default.
• W2022881140 cites W2148727203 @default.
• W2022881140 cites W2161761640 @default.
• W2022881140 cites W2169755310 @default.
• W2022881140 cites W2171401731 @default.
• W2022881140 doi "https://doi.org/10.1111/j.1360-0443.2008.02345.x" @default.
• W2022881140 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2652482" @default.
• W2022881140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19032530" @default.
• W2022881140 hasPublicationYear "2008" @default.
• W2022881140 type Work @default.
• W2022881140 sameAs 2022881140 @default.
• W2022881140 citedByCount "43" @default.
• W2022881140 countsByYear W20228811402012 @default.
• W2022881140 countsByYear W20228811402013 @default.
• W2022881140 countsByYear W20228811402014 @default.
• W2022881140 countsByYear W20228811402015 @default.
• W2022881140 countsByYear W20228811402016 @default.
• W2022881140 countsByYear W20228811402017 @default.
• W2022881140 countsByYear W20228811402018 @default.
• W2022881140 countsByYear W20228811402019 @default.
• W2022881140 countsByYear W20228811402020 @default.
• W2022881140 countsByYear W20228811402021 @default.
• W2022881140 countsByYear W20228811402022 @default.
• W2022881140 crossrefType "journal-article" @default.
• W2022881140 hasAuthorship W2022881140A5009339235 @default.
• W2022881140 hasAuthorship W2022881140A5015054723 @default.
• W2022881140 hasAuthorship W2022881140A5021252267 @default.
• W2022881140 hasAuthorship W2022881140A5038414404 @default.
• W2022881140 hasAuthorship W2022881140A5075961872 @default.
• W2022881140 hasBestOaLocation W20228811402 @default.
• W2022881140 hasConcept C118552586 @default.
• W2022881140 hasConcept C126322002 @default.
• W2022881140 hasConcept C127413603 @default.
• W2022881140 hasConcept C160735492 @default.
• W2022881140 hasConcept C162324750 @default.
• W2022881140 hasConcept C170493617 @default.
• W2022881140 hasConcept C185592680 @default.
• W2022881140 hasConcept C187320778 @default.
• W2022881140 hasConcept C194828623 @default.
• W2022881140 hasConcept C2426938 @default.
• W2022881140 hasConcept C27415008 @default.
• W2022881140 hasConcept C2777972943 @default.
• W2022881140 hasConcept C2779436514 @default.
• W2022881140 hasConcept C2781009140 @default.
• W2022881140 hasConcept C2781063702 @default.
• W2022881140 hasConcept C2781066024 @default.
• W2022881140 hasConcept C2908647359 @default.
• W2022881140 hasConcept C50522688 @default.
• W2022881140 hasConcept C55493867 @default.
• W2022881140 hasConcept C71924100 @default.
• W2022881140 hasConcept C98274493 @default.
• W2022881140 hasConcept C99454951 @default.
• W2022881140 hasConceptScore W2022881140C118552586 @default.
• W2022881140 hasConceptScore W2022881140C126322002 @default.
• W2022881140 hasConceptScore W2022881140C127413603 @default.
• W2022881140 hasConceptScore W2022881140C160735492 @default.
• W2022881140 hasConceptScore W2022881140C162324750 @default.
• W2022881140 hasConceptScore W2022881140C170493617 @default.
• W2022881140 hasConceptScore W2022881140C185592680 @default.
• W2022881140 hasConceptScore W2022881140C187320778 @default.
• W2022881140 hasConceptScore W2022881140C194828623 @default.
• W2022881140 hasConceptScore W2022881140C2426938 @default.
• W2022881140 hasConceptScore W2022881140C27415008 @default.
• W2022881140 hasConceptScore W2022881140C2777972943 @default.
• W2022881140 hasConceptScore W2022881140C2779436514 @default.
• W2022881140 hasConceptScore W2022881140C2781009140 @default.
• W2022881140 hasConceptScore W2022881140C2781063702 @default.

• next